SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-23-000777
Filing Date
2023-07-24
Accepted
2023-07-24 16:38:29
Documents
1
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 17312
  Complete submission text file 0000947871-23-000777.txt   19410
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-41747 | Film No.: 231105483

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Capital GP VI LLC (Reporting) CIK: 0001682115 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41747 | Film No.: 231105482

Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Issuer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)